Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Wyeth’s Viviant “Approvable” For Osteoporosis

Related Content

Wyeth’s Viviant Receives Second “Approvable” Letter For Osteoporosis Prevention

Dec 28 2007

Pfizer Files Lasofoxifene NDA For Treatment Of Osteoporosis

Jan 15 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window